Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK.
Pratik ChoudharyS de PortuA ArrietaJ CastañedaF M CampbellPublished in: Diabetic medicine : a journal of the British Diabetic Association (2019)
Real-world UK data show that increasing automation of insulin suspension reduces hypoglycaemia exposure in people with Type 1 diabetes.